Use of Pharmacogenetic Testing in Routine Clinical Practice Improves Outcomes for Psychiatry Patients

  • Ramsey T
  • Griffin E
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The present study was designed to investigate the pattern of time-dependent expression of peroxisome proliferator-activated receptors (PPAR, β, and γ) after global cerebral ischemia and reperfusion (I/R) damage in the rat hippocampus. Male Sprague Dawley (SD) rats were subjected to global cerebral I/R. The rat hippocampi were isolated to detect the expression of PPARs mRNA and protein levels at 30 min-30 d after I/R by RT-PCR and Western blot analysis, respectively. The expression levels of PPARs mRNA and protein in the rat hippocampus significantly increased and peaked at 24 h for PPAR and γ (at 48 h for PPARβ) after I/R, then gradually decreased, and finally approached control levels on d 30. The present results suggest that global cerebral I/R can cause obvious increases of hippocampal PPARs mRNA and protein expression within 15 d after I/R. These findings may help to guide the experimental and clinical therapeutic use of PPARs agonists against brain injury. © 2012 Hong Wang et al.

Cite

CITATION STYLE

APA

Ramsey, T., & Griffin, E. (2016). Use of Pharmacogenetic Testing in Routine Clinical Practice Improves Outcomes for Psychiatry Patients. Journal of Psychiatry, 19(4). https://doi.org/10.4172/2378-5756.1000377

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free